In a clinical trial, the administration of peptides derived from TOMM34, RNF43 and VEGFR significantly increased the levels of IgG against these antigens; specifically, the production of immunoglobulins against VEGFR correlated with improved overall survival of patients with advanced CRC [26]. Here, KDR is linked to colorectal carcinoma.